<DOC>
	<DOCNO>NCT02875743</DOCNO>
	<brief_summary>Invasive fungal disease ( IFD ) important cause mortality morbidity patient undergo intensive chemotherapy transplantation . This current study aim assess impact prophylactically use broad-spectrum anti-fungal agent posaconazole incidence IFD high risk patient aplastic anaemia undergo intensive chemotherapy , example acute myeloid leukaemia , allogeneic stem cell transplantation .</brief_summary>
	<brief_title>King 's Invasive Aspergillosis Study II</brief_title>
	<detailed_description />
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Posaconazole</mesh_term>
	<criteria>INCLUSION CRITERIA 1 . Adult â‰¥ 18 year 2 . Patients aplastic anaemia , MDS AML undergoing : IST ; Intensive chemotherapy induction chemotherapy ; RIC allogeneic HSCT 3 . Able swallow retain orally administer medication EXCLUSION CRITERIA 1 . Refusal inability consent 2 . Autologous HSCT 3 . Contraindicated medication 4 . Current evidence IFD diagnosis treatment 5 . Enrolled another study require alternative antifungal prophylaxis treatment 6 . Women pregnant lactate 7 . Women unable use apply effective contraception without interruption throughout duration study drug therapy willing pregnancy test course study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>